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Introduction {#sec007}
============

A reduction in mortality of patients with acute respiratory distress syndrome (ARDS; \[[@pone.0232720.ref001]\]) has been shown for low-tidal volume ventilation \[[@pone.0232720.ref002]\], prone positioning \[[@pone.0232720.ref003]--[@pone.0232720.ref005]\] and in one study on neuro-muscular blocking agents (NMBA) \[[@pone.0232720.ref006]\]. Two RCTs suggest a potential to improve outcome by ECMO in selected patients \[[@pone.0232720.ref007], [@pone.0232720.ref008]\]. Nevertheless, mortality of ARDS is about 40% \[[@pone.0232720.ref001], [@pone.0232720.ref009], [@pone.0232720.ref010]\]. Protracted recognition or even complete non-recognition of ARDS at all contributes to its high mortality \[[@pone.0232720.ref001], [@pone.0232720.ref010], [@pone.0232720.ref011]\]. ARDS remains unrecognized in two of three patients at the time of fulfillment of the ARDS criteria \[[@pone.0232720.ref001]\]. These findings suggest a low acceptance and/or sensitivity of the current definition.

ARDS is a *syndromic disease* without a sensitive and specific diagnostic test \[[@pone.0232720.ref012]\]. About 50 years after the first definition of ARDS and several modifications like the American-European Consensus Conference (AECC; \[[@pone.0232720.ref013]\]) also the most recent "Berlin-definition" is a matter of debate \[[@pone.0232720.ref014], [@pone.0232720.ref015]\]. AECC- and Berlin-definition are predominantly based on p~a~O~2~/F~i~O~2~ and neglect the impact of pulmonary compliance and other markers on the outcome of ARDS \[[@pone.0232720.ref016]\].

In addition to consensus-definitions several "informal" scores emerged such as the Murray (Lung Injury Score (LIS); \[[@pone.0232720.ref017]\]) which is based on predefined categories of p~a~O~2~/F~i~O~2~, PEEP, lung compliance and chest X-ray.

The combination of mean airway-pressure (P_maw) with p~a~O~2~/F~i~O~2~ defines the oxygenation-index (OI = P_maw \* F~i~O~2~ \* 100 / p~a~O~2~). Several studies demonstrated better prognostic capabilities of OI compared to pO~2~/F~i~O~2~ \[[@pone.0232720.ref018]--[@pone.0232720.ref020]\].

Furthermore, extravascular lung water index EVLWI has been suggested as ARDS-defining criterion \[[@pone.0232720.ref020]--[@pone.0232720.ref026]\].

Sensitive, specific and early diagnosis of ARDS is important to improve timing and allocation to specific interventions such as PP, NMBAs and ECMO \[[@pone.0232720.ref027]\]. Regarding side effects and resources required, optimized indication of these interventions is of high clinical and socio-economic interest. There is consensus that strategies to improve the effectiveness of ECMO are crucial. These strategies include an optimized patient selection. To optimize timing, a too early intervention in patients not in need for ECMO should be avoided. On the other hand, a protracted initiation of ECMO in a rescue-setting results in poor outcome \[[@pone.0232720.ref028]\].

Only few studies included systematic, repeated and early comparison of the predictive capacities of ARDS-definitions and scores regarding mortality ([Table 1](#pone.0232720.t001){ref-type="table"}).

10.1371/journal.pone.0232720.t001

###### Summary of studies comparing repeated prediction of outcome in acute respiratory distress syndrome ARDS.

![](pone.0232720.t001){#pone.0232720.t001g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reference                                                                                                                                         Setting; Number of patients                                                    Predictors                                                  EVLWI available   No. of measurements   Main result
  ------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ----------------------------------------------------------- ----------------- --------------------- -------------------------------------------------------------------------------------------------
  Villar et al. \[[@pone.0232720.ref029]\]                                                                                                          ARDS                                                                           p~a~O~2~/F~i~O~2~                                           no                1 measurement         Predictive regression model (including age, P_plat, and p~a~O~2~/F~i~O~2~) and APACHE-\
                                                                                                                                                                                                                                                                                                                                        • II significantly predict ICU-mortality.\
                                                                                                                                                                                                                                                                                                                                       ROC-AUCs:\
                                                                                                                                                                                                                                                                                                                                       Derivation cohort:\
                                                                                                                                                                                                                                                                                                                                        • model: 0.725 - 0.810\
                                                                                                                                                                                                                                                                                                                                        • - APACHE-II: 0.620 - 0.695

  Deriviation: 170 patients                                                                                                                         on day of fulfillment of ARDS APACHAPACHE                                                                                                                                          

  Plateu-pressure (P_plat)                                                                                                                                                                                                                                                                                                             

  Day-1 only                                                                                                                                                                                                                                                                                                                           

  Age                                                                                                                                                                                                                                                                                                                                  

  Validation: 50 patients ICU-mortality                                                                                                             APACHE-II                                                                                                                                                                          

  Kao et al. \[[@pone.0232720.ref030]\]                                                                                                             Severe acute respiratory failure (acute respiratory failure with \>24h of MV   SOFA (day-1)                                                no                1 day (SOFA)          OI in the first 3 days of mechanical ventilation and high SOFA independently predict mortality.

  3 days (PaO~2~/F~i~O~2~)                                                                                                                                                                                                                                                                                                             

  ROC-AUCs:\                                                                                                                                                                                                                                                                                                                           
  SOFA-score (day 1): 0.647                                                                                                                                                                                                                                                                                                            

  p~a~O~2~/F~i~O~2~, (day 1,3)                                                                                                                      3 days (OI)                                                                                                                                                                        

  OI (day 1, 3)                                                                                                                                     OI (day 3): 0.724                                                                                                                                                                  

  Change of OI within the first 3 days                                                                                                                                                                                                                                                                                                 

  100 patients                                                                                                                                                                                                                                                                                                                         

  Hospital mortality                                                                                                                                                                                                                                                                                                                   

  Dechert et al. \[[@pone.0232720.ref031]\]                                                                                                         Multicenter study (ALVEOLI database)                                           Day 1-4: Age, OI, age adjusted OI (AOI)                     no                4 measurements        Deriviation cohort:\
                                                                                                                                                                                                                                                                                                                                       Age: AUC=0.67 (day 1), similar results days 2-4

  541 patients                                                                                                                                      Day 1: p~a~O~2~/FiO~2~, age + p~a~O~2~/FiO~2~                                                                                                                                      

  4 days                                                                                                                                            OI: AUC=0.61 (day 1), similar results on days 2-4                                                                                                                                  

  AOI (day 1-4): AUC: 0.73, 0.70, 0.70, 0.74                                                                                                                                                                                                                                                                                           

  28-days-mortality                                                                                                                                 p~a~O~2~/F~i~O~2~: AUC=0.42 (day 1)                                                                                                                                                

  Age + PaO~2~/F~i~O~2~: AUC=0.52 (day 1)                                                                                                                                                                                                                                                                                              

  Validation cohorts                                                                                                                                                                                                                                                                                                                   

  FACCT: AOI (day 1-4): AUC: 0.70, 0.72, 0.73, 0.72                                                                                                                                                                                                                                                                                    

  ARMA: AOI (day 1-4): AUC: 0.74, 0.78, 0.77, 0.76                                                                                                                                                                                                                                                                                     

  Balzer et al. (32)                                                                                                                                ICU                                                                            AECC, Berlin, p~a~O~2~/F~i~O~2~, OI                         no                442 patients          OI better predicts mortality compared to p~a~O~2~/F~i~O~2~, AECC or Berlin.

  Hospital mortality                                                                                                                                                                                                                                                                                                                   

  7 measurements                                                                                                                                    OI is an independent predictor in the final model of regression analysis.                                                                                                          

  7 days                                                                                                                                            Best early prediction on days 3 and 4.                                                                                                                                             

  Own study                                                                                                                                         General ICU                                                                    AECC, Berlin, LIS, OI, EVLWI                                yes (49/99)                             Best prediction on day 2.

  99 patients                                                                                                                                                                                                                                                                                                                          

  49/99 patients with PiCCO and EVLWI                                                                                                               4 measurements                                                                 EVLWI and OI are independently associated with mortality.                                           

  Similar impact and cut-offs of EVLWI and OI in the multivariate analysis.                                                                                                                                                                                                                                                            

  28-days-mortality                                                                                                                                                                                                                                                                                                                    

  4 days                                                                                                                                            Sum of EVLWI and OI on day 2: ROC-AUC of 0.824                                                                                                                                     

  A cut-off of 19 for EVLWI (mL/kg) + OI (cmH~2~O/mmHg) on day 2 provided a sensitivity of 71% and a specificity of 79% to predict 28d-mortality.                                                                                                                                                                                      

  Sum EVLWI+OI+SOFA on day-2 provided a ROC-AUC of 0.856.                                                                                                                                                                                                                                                                              
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ARDS: Acute Respiratory Distress Syndrome; ICU: Intensive Care Unit; MV: Mechanical ventilation; EVLWI: Extra-vascular Lung Water Index; APACHE-II: Acute Physiology And Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; OI: Oxygenation Index; LIS: Lung Injury Score; AECC: American European Consensus Conference; ROC-AUC: Receiver-operating characteristics area under the curve

Therefore, we compared the early prediction of 28-days-mortality by AECC- and Berlin-definitions of ARDS, by OI, a modified Murray-score and---if available---by EVLWI in 100 ICU-patients with ARDS.

Materials and methods {#sec008}
=====================

Study design {#sec009}
------------

The study was conducted in a general ICU of a university hospital between May 2015 and September 2016. The protocol was approved by the institutional review board (Ethikkommission der Fakultät für Medizin der Technischen Universität München; 343/18 S) and registered (ISRCTN32938630). The need for informed consent was waived due to the observational design.

Data availability statement {#sec010}
---------------------------
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100 consecutive patients with ARDS according to the Berlin-definition \[[@pone.0232720.ref033]\] were included. No patients fulfilling this criterion were excluded. OI as well as grading according to the AECC- (acute lung injury (ALI), ARDS) and Berlin-definitions (mild, moderate, severe) of ARDS, modified Murray-score without radiological points (Murray_mod) were daily documented for four days after intubation and correlated with 28d-mortality. We did not include the radiological sub-score in the Murray-score, since the use of radiological assessment for the Murray-score has been questioned \[[@pone.0232720.ref034]\].

Irrespectively of the study, 49 patients were equipped with transpulmonary thermodilution (TPTD) monitoring (PiCCO; Pulsion Medical Systems SE; Feldkirchen, Germany) on the day of intubation. In these patients, EVLWI was documented daily. TPTD using the PiCCO-2-device was performed as described previously \[[@pone.0232720.ref020]\].

Statistics and endpoints {#sec011}
------------------------

There were two major goals of these analyses:

1.  To characterize the best early pulmonary predictor of 28-days-mortality in patients with ARDS.

2.  To characterize the best day(s) for early prediction of 28-days-mortality.

Primary endpoint: ROC-AUCs (Receiver-operating-characteristic areas under the curve) regarding the prediction of 28-days-mortality by AECC-definition, Berlin-definition, OI, Murray_mod were calculated on the 1st, 2nd, 3rd and 4th day after intubation.

In the subgroup with TPTD-monitoring, also EVLWI was investigated as potential predictor of 28-days-mortality (ROC-AUCs).

Secondary endpoints: Since outcome of patients with ARDS is strongly associated with non-pulmonary organ impairment \[[@pone.0232720.ref035]\], we also investigated the prediction of 28-days-mortality by APACHE-II and SOFA.

To account for interactions and potential independent associations of several predictors with outcome, we performed three binary regression analyses (Wald backward selection) regarding 28days-mortality.

Two regression analyses were restricted to the subgroup with TPTD monitoring. This allowed for analysing prediction by EVLWI in addtion to standard ARDS-scores.

In a first step, we included OI, Berlin, AECC, Murray_mod and EVLWI.

In a second step, we also included the general ICU-scores APACHE-II and SOFA in addition to OI and EVLWI.

Prevalence of TPTD-monitoring in about half of the patients allowed to analyse a potential impact of *„TPTD-monitoring per se"* with 28d-mortality as a major secondary endpoint. Necessarily, this analysis was performed *in the totality* of patients (49 patients with and 50 patients without TPTD-monitoring). For this analysis, we included APACHE-II, SOFA and TPTD-monitoring.

For comparison of baseline or other characteristics between groups, we used the Chi-square-test and the Wilcoxon-test for unpaired samples.

Due to the online documentation of all relevant data only few variables were missing due to technical or organizational reasons (e.g. absence from the ICU due to external examinations). In this case statistical tests were performed based on all measurements with valid data.

The sample size was calculated based on the assumption of a rate of correct prediction of 67% regarding 28-days mortality. This would require a study population of n=65 to demonstrate a significantly better prediction of the outcome compared to prediction "by chance" (67% vs. 50%) with p \<0.05 and a statistical power of 80% (one group; dichotomous primary endpoint).

Assuming a drop-out rate (deaths, transfer within the first days) of 33% until day-4, n=100 patients were included.

All statistical anlyses were performed using IBM SPSS 26.

Results {#sec012}
=======

Patients´ characteristics {#sec013}
-------------------------

Due to early transfer to another hospital and early discharge, for one patient final information on 28-d mortality was missing. Therefore, 99 complete data sets were finally analyzed.

Patients' *baseline characteristics* on day 1 are shown in [Table 2](#pone.0232720.t002){ref-type="table"}. 40.4% of the patients suffered from primary, 59.6% from secondary ARDS. Primary ARDS was defined as patients suffering from direct lung injury including pneumonia (bacterial, viral, fungal, or opportunistic), aspiration of gastric contents, pulmonary contusion, inhalation injury or patients with near drowning), wheras for patients with secondary ARDS patients no underlying causes for primary ARDS could be identified (e.g. sepsis of nonpulmonary source, nonthoracic trauma or hemorrhagic shock, pancreatitis, major burn injury, drug overdose, transfusion of blood products, cardiopulmonary bypass, reperfusion edema after lung transplantation or embolectomy) \[[@pone.0232720.ref009]\].

10.1371/journal.pone.0232720.t002

###### Patients' basic characteristics on day 1.

![](pone.0232720.t002){#pone.0232720.t002g}

  Parameter                          All patients (n=99)   Primary ARDS (n=40)   Secondary ARDS (n=59)   p-value   Patients with TPTD (n=49)   Patients without TPTD (n=50)   p-value
  ---------------------------------- --------------------- --------------------- ----------------------- --------- --------------------------- ------------------------------ ---------
  Age (years)                        62±14                 63±14                 62±14                   0.697     60±14                       65±13                          0.080
  Male sex (no; %)                   54 (55%)              24 (60%)              30 (51%)                0.369     26 (53%)                    28 (56%)                       0.769
  Height (1)                         172±8                 172±8.9               172±7                   0.868     172±7                       172±9                          0.752
  Weight (kg)                        76±14                 73±12                 77±15                   0.201     76±15                       76±13                          0.934
  SOFA score                         11±4                  8.48±4.51             12.03±3.86              \<0.001   11.45±4.58                  9.76±4.24                      0.070
  APACHE-II score                    22±7                  21±7                  22±7                    0.528     22±8                        21±7                           0.456
  P~a~O~2~/FiO~2~ (mmHg)             191±68                180±66                197±68                  0.253     188±62                      195±73                         0.398
  Oxygenation index (cmH~2~O/mmHg)   8.41±6.4              9.6±8.4               7.6±4.2                 0.162     8.4±4.4                     8.4±8.0                        0.116

RDS: Acute Respiratory Distress Syndrome; APACHE-II: Acute Physiology And Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; TPTD: transpulmonary thermodiltion

Patients with primary ARDS had a significantly lower SOFA score on day 1 (8.48 vs. 12.03; p\<0.001).

Patients with PiCCO-monitoring showed a trend to higher SOFA-values compared to the patients without PiCCO (11.45 vs. 9.76; p=0.070).

Mortality-analyses: All patients {#sec014}
--------------------------------

28-days-mortality was 40 out of 99 (40.1%).

On day-1, the largest ROC-AUC among the four respiratory scores was provided by OI (AUC=0.689; p=0.002; [Fig 1](#pone.0232720.g001){ref-type="fig"}; [Table 3](#pone.0232720.t003){ref-type="table"}). Furthermore, the Berlin-definition was significantly associated with 28-days-mortality (AUC=0.664; p=0.006), whereas AECC and Murray_mod were not predictive.

![ROC-AUC regarding 28d-mortality (all patients; day 1).\
OI: oxygenation index; AECC: American European Consensus Conference; Murray_mod: modified Murray-score (sum of points without radiological points); AUC: area under the curve. APACHE-II: Acute Physiology And Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment.](pone.0232720.g001){#pone.0232720.g001}

10.1371/journal.pone.0232720.t003

###### Prediction of 28-days-mortality by OI, Berlin-, AECC-definition and modified Murray-score: All patients.
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  Predictor    Day-1   Day-2         Day-3   Day-4   Mean-AUC                                                                          
  ------------ ------- ------------- ------- ------- ------------- ------- ------- ------------- ------- ------- ------------- ------- -------
  OI           0.689   0.576-0.801   0.002   0.632   0.513-0.752   0.034   0.603   0.470-0.736   0.134   0.577   0.439-0.716   0.280   0.625
  Berlin       0.664   0.551-0.777   0.006   0.644   0.526-0.762   0.021   0.589   0.456-0.722   0.196   0.476   0.337-0.616   0.740   0.593
  AECC         0.614   0.501-0.728   0.055   0.620   0.502-0.739   0.054   0.585   0.452-0.718   0.219   0.476   0.336-0.615   0.732   0.574
  Murray_mod   0.562   0.441-0.683   0.296   0.582   0.459-0.704   0.192   0.620   0.489-0.751   0.082   0.514   0.375-0.654   0.841   0.577
  Mean-AUC     0.632   0.620         0.599   0.511                                                                                     

OI: Oxygenation Index; AECC: American European consenus conference; Murray_mod: modified Murray-score; AUC: Area under the curve; 95%-CI: 95% confidence interval

While the AUC for the APACHE-II-score (AUC=0.667; p=0.005; [Table 4](#pone.0232720.t004){ref-type="table"}) was smaller than for OI, the SOFA-score had the largest AUC of all predictors (AUC=0.763; p\<0.001) on day-1.

10.1371/journal.pone.0232720.t004

###### Prediction of 28-days-mortality by SOFA-and APACHE-II-score: All patients and patients with PiCCO-monitoring on all four days (d1-d4).

![](pone.0232720.t004){#pone.0232720.t004g}

  Cohort/ Subgroup              Day-1         Day-2         Day-3   Day-4                                                                                               
  --------------------- ------- ------------- ------------- ------- ------------- ------------- ------- ------------- ------------- ------- ------------- ------------- -------
  All patients          SOFA    0.763         0.669-0.856   0.000   0.780         0.686-0.875   0.000   0.796         0.696-0.895   0.000   0.790         0.686-0.894   0.000
  APACHE-II             0.667   0.559-0.776   0.005         0.680   0.570-0.790   0.004         0.684   0.562-0.806   0.008         0.674   0.549-0.800   0.015         
  Patients with PiCCO   SOFA    0.774         0.637-0.912   0.002   0.775         0.638-0.912   0.002   0.755         0.610-0.901   0.005   0.712         0.545-0.878   0.033
  APACHE-II             0.627   0.459-0.795   0.155         0.614   0.451-0.776   0.203         0.599   0.432-0.766   0.275         0.649   0.473-0.826   0.132         

AUC: Area under the curve; 95%-CI: 95% confidence interval; SOFA: Sequential Organ Failure Assessment; APACHE-II: Acute Physiology And Chronic Health Evaluation

On day-2, OI (AUC=0.632; p=0.034) and Berlin-definition (AUC=0.644; p=0.021; [Fig 2](#pone.0232720.g002){ref-type="fig"}; [Table 3](#pone.0232720.t003){ref-type="table"}) predicted 28-days-mortality with significant p-values, but poor ROC-AUCs. AECC-definition and Murray_mod were not predictive.

![ROC-AUC regarding 28d-mortality (all patients; day 2).\
OI: oxygenation index; AECC: American European Consensus Conference; Murray_mod: modified Murray-score (sum of points without radiological points); AUC: area under the curve. APACHE-II: Acute Physiology And Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment.](pone.0232720.g002){#pone.0232720.g002}

SOFA (AUC=0.780; p\<0.001; [Table 4](#pone.0232720.t004){ref-type="table"}) predicted 28-days-mortality better than the APACHE-II (AUC=0.680; p=0.004).

On day-3 and on day-4 none of the four ARDS-scores significantly predicted 28-days-mortality (Figs [3](#pone.0232720.g003){ref-type="fig"} and [4](#pone.0232720.g004){ref-type="fig"}; [Table 3](#pone.0232720.t003){ref-type="table"}).

SOFA (AUC=0.796; p\<0.001) provided larger AUCs than APACHE-II (AUC=0.684; p=0.008) on day-3 and day-4 (AUC=0.790; p\<0.001 vs. AUC=0.674; p=0.015; [Table 4](#pone.0232720.t004){ref-type="table"}).

![ROC-AUC regarding 28d-mortality (all patients; day 3).\
OI: oxygenation index; AECC: American European Consensus Conference; Murray_mod: modified Murray-score (sum of points without radiological points); AUC: area under the curve. APACHE-II: Acute Physiology And Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment.](pone.0232720.g003){#pone.0232720.g003}

![ROC-AUC regarding 28d-mortality (all patients; day 4).\
OI: oxygenation index; AECC: American European Consensus Conference; Murray_mod: modified Murray-score (sum of points without radiological points); AUC: area under the curve. APACHE-II: Acute Physiology And Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment.](pone.0232720.g004){#pone.0232720.g004}

OI was the best predictor among the respiratory scores with a mean AUC of 0.625 (see [Table 3](#pone.0232720.t003){ref-type="table"}), whereas the mean AUCs for all other scores were below the critical threshold of 0.6.

Regarding the *timing of prognosis*, the best prediction of 28-days-mortality was found on day-1 (mean ROC-AUC=0.632) and day-2 (mean ROC-AUC=0.620; see [Table 3](#pone.0232720.t003){ref-type="table"}), whereas mean ROC-AUCs were below 0.6 on day-3 and on day-4.

Mortality-analyses: Subgroup with TPTD-monitoring (n=49) {#sec015}
--------------------------------------------------------

Among patients with TPTD-monitoring, EVLWI had the best predictive capacities ([Fig 5](#pone.0232720.g005){ref-type="fig"}; [Table 5](#pone.0232720.t005){ref-type="table"}): EVLWI provided the largest ROC-AUC on day-2 (AUC=0.786; p=0.001). EVLWI was also predictive on day-1 (AUC=0.712; p=0.018). EVLWI was the only parameter predicting 28-days-mortality on day-3 (AUC=0.692; p=0.035). The mean AUC for day-1 to day-4 was 0.696 for EVLWI ([Table 5](#pone.0232720.t005){ref-type="table"}). OI was predictive on day-1 (AUC=0.789; p=0.001) and on day-2 (AUC=0.734; p=0.009), but not on day-3 and day-4. Next to EVLWI, OI provided the largest mean ROC-AUC (0.695; [Table 5](#pone.0232720.t005){ref-type="table"}).

![Thermoplot illustrating ROC-AUCs of single parameters, scores and combined models within four days after intubation in patients with PiCCO-monitoring.\
Y-axis ranges from 0.5 (worthless for prediction; intense blue) to 1.0 and 0.0 (best prediction; intense red). AUC: area under the curve.OI: oxygenation index; EVLWI: Extra-vascular Lung Water Index; AECC: American European Consensus Conference; Murray_mod: modified Murray-score (sum of points without radiological points); AUC: area under the curve. APACHE-II: Acute Physiology And Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment.](pone.0232720.g005){#pone.0232720.g005}

10.1371/journal.pone.0232720.t005

###### Prediction of 28-days-mortality by OI, Berlin-, AECC-definition, Murray-score and EVLWI: Patients with PiCCO-monitoring on all four days (d1-d4).
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               Day-1   Day-2         Day-3   Day-4   Mean-AUC                                                                          
  ------------ ------- ------------- ------- ------- ------------- ------- ------- ------------- ------- ------- ------------- ------- -------
  OI           0.789   0.647-0.931   0.001   0.734   0.588-0.880   0.009   0.649   0.479-0.818   0.102   0.609   0.425-0.794   0.270   0.695
  Berlin       0.697   0.535-0.860   0.027   0.683   0.518-0.847   0.041   0.578   0.401-0.754   0.393   0.456   0.265-0.646   0.655   0.604
  AECC         0.656   0.494-0.819   0.080   0.646   0.481-0.811   0.101   0.574   0.398-0.751   0.413   0.462   0.269-0.654   0.699   0.585
  Murray_mod   0.659   0.499-0.819   0.075   0.675   0.513-0.838   0.049   0.638   0.468-0.808   0.129   0.522   0.335-0.709   0.823   0.624
  EVLWI        0.712   0.562-0.862   0.018   0.786   0.653-0.919   0.001   0.692   0.531-0.852   0.035   0.595   0.412-0.778   0.340   0.696
  Mean-AUC     0.703   0.705         0.626   0.529                                                                                     

OI: Oxygenation-index; AECC: American European consenus conference; Murray_mod: modified Murray-score; AUC: Area under the curve; 95%-CI: 95% confidence interval

The Berlin-definition was associated with 28-days-mortality on day-1 (AUC=0.697; p=0.027) and on day-2 (AUC=0.683; p=0.041), but not on day-3 and day-4. The mean ROC-AUC over four days (AUC=0.604) was substantially smaller for the Berlin-definition than for EVLWI and OI.

Murray_mod was predictive only on day-2 (AUC=0.675; p=0.049). The mean ROC-AUC (AUC=0.624) for Murray_mod was slightly larger than for the Berlin-definition.

The AECC-definition did not predict 28-days-mortality on any day and provided the smallest mean ROC-AUC (AUC=0.585).

Regarding the *timing of prognosis*, as for the totality of patients, the best prediction of 28-days-mortality was found on day-1 (mean AUC=0.703) and day-2 (mean AUC=0.705; [Table 5](#pone.0232720.t005){ref-type="table"}; [Fig 5](#pone.0232720.g005){ref-type="fig"}).

Multivariate analysis including ARDS-scores and EVLWI {#sec016}
-----------------------------------------------------

In binary regression analysis regarding 28-days-mortality including OI, Berlin, AECC, Murray_mod and EVLWI, only EVLWI (p=0.007) and OI (p=0.006) were independently associated with 28-days-mortality.

The B- (-0.105 and -0.124), Wald- (7.294 and 7.435) and p-values (p=0.007 and p=0.006) in the regression equation were similar for EVLWI and OI. This implicates that both parameters had a similar impact and similar absolute values in the model. These findings suggests that simple addition (OI+EVLWI) or multiplication (OI\*EVLWI) could provide similar predictive capacities as the more complex model (prediction formula: 2.917-0.124\*OI-0.105\*EVLWI).

As shown in [Fig 5](#pone.0232720.g005){ref-type="fig"} the complete regression formula as well as the simplified formulas EVLWI+OI and EVLWI\*OI outscored all ARDS-scores and single parameters on all four days.

The best day to predict 28-days-mortality by the combination of EVLWI and OI was day-2 with ROC-AUCs of up to 0.824.

A cut-off of 19 for the sum of EVLWI (mL/kg)772 + OI (cmH~2~O/mmHg) on day-2 provided a sensitivity of 71% and a specificity of 79% to predict 28-days-mortality.

As for the totality of patients, SOFA better predicted mortality compared to APACHE-II. The largest AUCs for SOFA and APACHE-II were found on day-2 (SOFA: AUC=0.775; APACHE-II: AUC=0.614). However, the AUCs on day-2 were smaller than for the combinations of EVLWI and OI (0.822-0.824; [Fig 5](#pone.0232720.g005){ref-type="fig"}; [Table 5](#pone.0232720.t005){ref-type="table"}).

For *validation*, we re-analyzed an independent dataset from a previous study \[[@pone.0232720.ref020]\]. This analysis demonstrated significant and comparable ROC-AUCs for „OI+EVLWI" (day-1: AUC=0.676; p=0.046; day-3: AUC=0.772; p=0.002; [Fig 6](#pone.0232720.g006){ref-type="fig"}) and the more complex „OI and EVLWI-model" (day-1: AUC=0.686; p=0.036; day-3: AUC=0.789; p=0.001).

![Validation-study (dataset (n=50) from reference \[[@pone.0232720.ref020]\]): ROC-AUC regarding mortality.\
The models OI_and_EVLWI were calculated from the regression formula derived from this study (evaluation study). OI: oxygenation index; EVLWI: Extra-vascular Lung Water Index. AUC: area under the curve.](pone.0232720.g006){#pone.0232720.g006}

Prediction of mortality: Combination of SOFA with EVLWI and OI {#sec017}
--------------------------------------------------------------

In the next step, we performed binary regression analysis regarding 28-days-mortality including SOFA-, APACHE-II-score, OI and EVLWI. While APACHE-II did not independently predict 28d-mortality, EVLWI (p=0.018), OI (p=0.022) and SOFA (p=0.015) were independent predictors of 28-days-mortality.

Finally, *univariate comparison of patients with and without PiCCO-monitoring* showed a trend to lower mortality in patients with PiCCO-monitoring (16/49 (33%) vs. 24/50 (48%); p=0.12) despite a trend to a higher baseline-SOFA-score (11.45±4.58 vs. 9.76±4.24; p=0.070).

In binary regression analysis including "use of PiCCO-monitoring", SOFA and APACHE-II, only "use of PiCCO-monitoring" (p=0.007) and lower SOFA-score (p\<0.001) were independently associated with a lower 28-days-mortality.

Discussion {#sec018}
==========

Protracted or even non-recognititon of ARDS contributes to its high mortalitiy. This might be due to low nurse-to-patient ratios, low physician-to-patient ratios, older patient age, higher p~a~O~2~/F~i~O~2~ ratio, and the absence of of pneumonia or pancreatitis. In a recent trial, all these factors were independently associated with higher probability of non-recognition of ARDS \[[@pone.0232720.ref001]\]. However, early recognition and grading of ARDS is crucial, since the effectiveness of several therapeutic measures depends on their early initiation \[[@pone.0232720.ref002], [@pone.0232720.ref004], [@pone.0232720.ref006], [@pone.0232720.ref010], [@pone.0232720.ref036]\]. This also applies to ECMO \[[@pone.0232720.ref028], [@pone.0232720.ref037]\].

Our analyses regarding timing and predictors of 28-days-mortality showed the following results:

1.  OI better predicts 28-days-mortality compared to Berlin-definition, AECC and Murray_mod.

2.  The best predictive capacities were found within the first two days after intubation.

3.  EVLWI is a strong and independent predictor of 28-days-mortality.

4.  The combination of EVLWI and OI further increases the predictive capacities of each parameter alone. „OI+EVLWI" provides larger ROC-AUCs than SOFA and APACHE-II on the first two days.

5.  SOFA better predicted 28-days-mortality than APACHE-II.

6.  EVLWI, OI and SOFA were independently associated with 28-days-mortality.

7.  Furthermore, TPTD-monitoring was independently associated with a lower 28-days-mortality.

Similar to previous studies, we found poor prognostic capacities of predictors mainly based on p~a~O~2~/F~i~O~2~. The predictive capacities of the Berlin-definition were poor even in the primary validation-study: the ROC-AUC was only slightly better compared to the AECC-definition (AUC 0.577 vs. 0.536) and below the minimum threshold of 0.6 \[[@pone.0232720.ref033]\]. Limited predictive capacities of AECC, Berlin and p~a~O~2~/F~i~O~2~ were found in numerous more recent trials \[[@pone.0232720.ref032], [@pone.0232720.ref038]--[@pone.0232720.ref041]\].

Also the Murray/LIS-score is strongly driven by p~a~O~2~/F~i~O~2~. It includes four categories of p~a~O~2~/F~i~O~2~, PEEP, compliance and radiological findings. Among these four parameters, only p~a~O~2~/F~i~O~2~ and PEEP were significantly different between survivors and non-survivors in a recent study \[[@pone.0232720.ref034]\].

Several reasons for the poor performance of p~a~O~2~/F~i~O~2~, AECC, Berlin and Murray need to be discussed. The cut-offs of 100, 175, 200, 225 and 300mmHg used in these scores are arbitrary and poorly validated. Furthermore, p~a~O~2~/F~i~O~2~ strongly dependends on ventilatory data including PEEP, inspiration/exspiration-ratio, driving-pressure and even F~i~O~2~ itself. Inclusion of minimum (Berlin) or categorized (Murray; \[[@pone.0232720.ref017]\] information of PEEP did not substantially improve prediction compared to AECC. Finally, all three scores do not account for the non-linear relationship of p~a~O~2~ and F~i~O~2~: As shown by Allardet-Servent and co-workers \[[@pone.0232720.ref042]\], p~a~O~2~/F~i~O~2~ strongly increases with higher values of F~i~O~2~ \[[@pone.0232720.ref042]\].

The strong performance of OI in our study is in line with several previous studies \[[@pone.0232720.ref019], [@pone.0232720.ref030], [@pone.0232720.ref032], [@pone.0232720.ref038], [@pone.0232720.ref043]--[@pone.0232720.ref046]\]. Incorporation of P_maw includes substantial additional information, since P_maw in addition to p~a~O~2~/F~i~O~2~ reflects PEEP, inspiration/expiration-ratio, peak-pressure, delta-pressure and ventilation-mode (assisted vs. controlled). The strong improvement of prediction by inclusion of P_maw is further emphasized by the strong performance of the oxygenation *saturation* index \[[@pone.0232720.ref047]\] in several recent studies \[[@pone.0232720.ref038], [@pone.0232720.ref048]--[@pone.0232720.ref050]\]. OSI replaces p~a~O~2~ by percutaneous oxygen saturation: $$OSI\mspace{360mu} = \mspace{360mu} 100*P\_ maw*F_{i}O_{2}/S_{a}O_{2}$$

Best prediction of outcome on *day-2* in our study is in line with some \[[@pone.0232720.ref030], [@pone.0232720.ref031], [@pone.0232720.ref041]\], but not all of the few studies performing sequential prediction of mortality in ARDS. The study by Balzer et al. \[[@pone.0232720.ref032]\] analyzed prediction of mortality on day-1 to day-7 in 442 patients. It showed increasing predictive capacities from day-1 to day-3 and comparable ROC-AUCs from day-3 to day-7. However, two thirds of the patients extracted from a seven-year-database had been transferred from other hospitals, and 58% were treated with extracorporeal lung-assist after transfer. Both, transfer with previous ventilation and extracorporeal lung-support might have influenced the best time of prediction.

The strong performance of EVLWI in our study is supported by previous data, since EVLWI has been associated with mortality in numerous studies \[[@pone.0232720.ref020], [@pone.0232720.ref025], [@pone.0232720.ref051]--[@pone.0232720.ref056]\].

Some of these studies also demonstrated *independent* association of EVLWI with mortality in addition to APACHE-II \[[@pone.0232720.ref020]\], SOFA \[[@pone.0232720.ref055], [@pone.0232720.ref057]\] and SAPS \[[@pone.0232720.ref056]\]. Interestingly, in the studies by Mallat \[[@pone.0232720.ref057]\] and Craig \[[@pone.0232720.ref055]\], EVLWI and SOFA had similar odds ratios in the multivariate analyses. These data suggest a similar impact in a combined model which supports our finding that EVLWI, OI and SOFA were independently and to similar degree associated with 28-days-mortality.

While the combination of OI and EVLWI might be usefull for *selection* of patients for ECMO, SOFA might be used as an *exclusion criterion* for ECMO: Several ECMO registries and EOLIA suggest that even early ECMO does not improve outcome in patients with high SOFA-scores \[[@pone.0232720.ref003], [@pone.0232720.ref008], [@pone.0232720.ref058]--[@pone.0232720.ref061]\].

Finally, the finding that the early use of TPTD-monitoring „per se" independently reduced mortality in patients with ARDS is of high interest.

As expected according to the local standard, patients with PiCCO-monitoring available within 24h after intubation showed a trend to more severe organ impairment (mean SOFA 11.45 vs. 9.76; p=0.070).

A recent study suggests increases in mortality of about 7% for each SOFA-point \[[@pone.0232720.ref062]\]. Accordingly, mortality should be about 13% higher in our patients with PiCCO-monitoring. However, it was 15% lower (33% vs. 48%). This reduction of the predicted mortality-difference by 28% by advanced monitoring "per se" should be interpreted with caution, although these findings are in line with previous studies suggesting potentially beneficial effects of PiCCO-monitoring with \[[@pone.0232720.ref063]--[@pone.0232720.ref067]\] and without \[[@pone.0232720.ref068], [@pone.0232720.ref069]\] pre-defined algorithms. Similar to our study, a RCT in patients with ARDS and septic shock demonstrated a comparable mortality between groups despite a 17% percent higher predicted mortality according to SOFA and APACHE-II in the PiCCO-group compared to the controls \[[@pone.0232720.ref065], [@pone.0232720.ref066]\].

Strengths and practical applications {#sec019}
------------------------------------

This is one of few studies comparing daily prediction of mortality in ARDS by AECC, Berlin, Murray/LIS and OI over four days after intubation. Availability of TPTD-monitoring in about 50% of the patients allowed for comparing these predictors to EVLWI in a substantial subgroup, and for analyzing the impact of PiCCO-monitoring per se.

The usefulness of EVLWI and OI could be validated in an independent validation group.

Limitations {#sec020}
-----------

Evaluation and validation were performed in a single center. TPTD-data were obtained in only half of the patients. Furthermore, prediction of a high mortality with high sensitvity and specifity by a single or few parameters in a mono-centric cohort rarely justifies limitation of therapy in an individual patient. However, in addition to a practical use (better allocation to different treatment options; in particular allocation of patients „at need" to limited ressources) predictors help to compare patient populations in studies or and audits.

Another limitation is our „pragmatic" approach with crossover--comparison of several predictors of 28-days on four different days. This might induce a kind of „immortality bias": Since a substantial number of patients died or was transferred within the first three days, the basis of observation and the number of patients analysed on day-4 were different from day-1. From a statistician´s viewpoint, one could overcome this problem by a limitation of the anaylsis to patients surviving at least to day-5. However, this would eliminate half of the non-survivors (20 out 40) who died within the first four days. Regarding better allocation of patients to early treatment options such as ECMO, this approach would eliminate the most interesting subgroup of our study. On the other hand, this approach would focus on predictors of *late* mortality. Ex-post analyses of this study demonstrate that the SOFA-score best predicted late mortality, whereas P/F-ratio, AECC- and Berlin-definition and modified Murray-score were poor predictors (data not shown). Next to SOFA-score, the largest AUCs to predict death after day-4 were provided by Oxygenation-Index (AUC=0.700; p=0.008) on day-1, and by EVLWI on day-2 (AUC0.751; p=0.010) in the subgroup of patients with PiCCO-monitoring.

Conclusions {#sec021}
===========

Prognosis of ARDS-patients can be established within the first two days after intubation.

EVLWI, OI and SOFA were the best predictors. Similar cut-offs and numerical values facilitate their use in simple models resulting from addition of the raw values.

TPTD-monitoring „per se" was independently associated with reduced mortality.

AECC

:   American European Consensus Conference

AOI

:   Age-adjusted oxygenation index

APACHE

:   Acute physiology and chronic health evaluation

ARDS

:   Acute respiratory distress syndrome

AUC

:   Area under the curve

ECMO

:   Extra-corporeal membrane oxygenation

EVLWI

:   Extravascular lung water index

F~i~O~2~

:   Fraction of inspired oxygen

I/E

:   Inspiration/exspiration

ICU

:   Intensive care unit

LIS

:   Lung injury score

MV

:   Mechanical ventilation

NMBA

:   Neuro-muscular blocking agent

OI

:   Oxygenation index

OR

:   Odds ratio

OSI

:   Oxygenation saturation index

P_maw

:   Mean airway pressure

P_plat

:   Plateau pressure

p~a~O~2~

:   Arterial partial oxygen pressure

PEEP

:   Positive end-expiratory pressure

PP

:   Prone positioning

RCT

:   Randomized controled trial

ROC

:   Receiver operating caracteristic

SaO2

:   Arterial oxygen saturation

SAPS

:   Simplified acute physiology score

SOFA

:   Sequential organ failure assesment

TPTD

:   Transpulmonary thermodilution
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